Woodward Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WOODWARD, and what generic alternatives to WOODWARD drugs are available?
WOODWARD has fourteen approved drugs.
There is one US patent protecting WOODWARD drugs.
There are twenty-four patent family members on WOODWARD drugs in fourteen countries and fourteen supplementary protection certificates in five countries.
Drugs and US Patents for Woodward
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Woodward | FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | fluconazole | INJECTABLE;INJECTION | 077909-002 | May 26, 2010 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Woodward | AVANDIA | rosiglitazone maleate | TABLET;ORAL | 021071-004 | May 25, 1999 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Woodward | LOVAZA | omega-3-acid ethyl esters | CAPSULE;ORAL | 021654-001 | Nov 10, 2004 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Woodward | ACIPHEX | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 020973-002 | Aug 19, 1999 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Woodward
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Woodward | LUNESTA | eszopiclone | TABLET;ORAL | 021476-001 | Dec 15, 2004 | 7,381,724*PED | ⤷ Try a Trial |
Woodward | AVANDIA | rosiglitazone maleate | TABLET;ORAL | 021071-004 | May 25, 1999 | 5,002,953*PED | ⤷ Try a Trial |
Woodward | COREG | carvedilol | TABLET;ORAL | 020297-003 | Sep 14, 1995 | 4,503,067*PED | ⤷ Try a Trial |
Woodward | AVANDIA | rosiglitazone maleate | TABLET;ORAL | 021071-002 | May 25, 1999 | 5,741,803*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for WOODWARD drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Capsules | 10 mg and 20 mg | ➤ Subscribe | 2008-03-18 |
➤ Subscribe | Extended-release Capsules | 80 mg | ➤ Subscribe | 2007-11-19 |
➤ Subscribe | Capsule | 0.5 mg/0.4 mg | ➤ Subscribe | 2010-10-26 |
➤ Subscribe | Tablets | 1 mg, 2 mg and 3 mg | ➤ Subscribe | 2008-12-15 |
➤ Subscribe | Extended-release Capsules | 40 mg | ➤ Subscribe | 2007-12-21 |
➤ Subscribe | Capsules | 0.5 mg | ➤ Subscribe | 2007-10-29 |
➤ Subscribe | Capsules | 1 g | ➤ Subscribe | 2008-11-10 |
International Patents for Woodward Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 101078636 | ⤷ Try a Trial |
Canada | 2563689 | ⤷ Try a Trial |
Japan | 2005506336 | ⤷ Try a Trial |
South Korea | 20100063825 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Woodward Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0306228 | C300034 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ROSIGLITAZONE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN/OF EEN FARMACEUTISCH AANVAARDBAAR SOLVAAT, IN HET BIJZONDER ROSIGLITAZONE MALEAAT; REGISTRATION NO/DATE: EU/1/00/137/001 - EU/1/00/137/012 20000711 |
0658161 | 39/2000 | Austria | ⤷ Try a Trial | PRODUCT NAME: ROSIGLITAZONE MALEAT; NAT. REGISTRATION NO/DATE: EU/1/00/137/001 - EU/1/00/137/012 20000711; FIRST REGISTRATION: LI 55176 19990929 |
0719278 | 23/2003 | Austria | ⤷ Try a Trial | PRODUCT NAME: DUTASTERIDE, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SOLVATES; NAT. REGISTRATION NO/DATE: 1-24844, 1-24845 20030217; FIRST REGISTRATION: SE 17871, 17872 20020719 |
0306228 | SPC/GB01/002 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: 5-(4-(2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY) BENZYL)-2,4-THIAZOLIDINEDIONE, "ROSIGLITAZONE" ITS TAUTOMERS, PHARMACEUTICALLY ACCEPTABLE SALTS, SUCH AS THE MALEATE, AND PHARMACEUTICALLY ACCEPTABLE SOLVATES.; REGISTERED: CH 55176 02 19990929; CH 55176 03 19990929; CH 55176 04 19990929; UK EU/1/00/137/001 20000711; UK EU/1/00/137/002 20000711; UK EU/1/00/137/003 20000711; UK EU/1/00/137/004 20000711; UK EU/1/00/137/005 20000711; UK EU/1/00/137/006 20000711; UK EU/1/00/137/007 20000711; UK EU/1/00/137/008 20000711; UK EU/1/00/137/009 20000711; UK EU/1/00/137/010 20000711; UK EU/1/00/137/011 20000711; UK EU/1/00/137/012 20000711 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.